Copernicus revisited: amyloid beta in Alzheimer's disease.
about
The effects of cholesterol on learning and memory.Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-betaThe biochemical aftermath of anti-amyloid immunotherapy.Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age.Feasibility of β-sheet breaker peptide-H102 treatment for Alzheimer's disease based on β-amyloid hypothesis.Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Antioxidants as treatment for neurodegenerative disorders.Neuroplasticity in Alzheimer's disease.The application of functional genomics to Alzheimer's disease.Barriers to developing a valid rodent model of Alzheimer's disease: from behavioral analysis to etiological mechanismsAlzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of ratsAmyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersTreating the lesions, not the disease.Fruit polyphenols and their effects on neuronal signaling and behavior in senescence.Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.The role of iron as a mediator of oxidative stress in Alzheimer disease.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.The dark sides of amyloid in Alzheimer's disease pathogenesis.The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.The human β-amyloid precursor protein: biomolecular and epigenetic aspects.Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome.Alzheimer's disease: ageing-related or age-related? New hypotheses from an old debate.Enhanced cell death in hippocampus and emergence of cognitive impairments following a localized mini-stroke in hippocampus if preceded by a previous episode of acute stress.Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.Mark A. Smith: neurocytochemistry innovator.Ill-fated amyloid-beta vaccine.The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing.Oil Palm Phenolics Inhibit the In Vitro Aggregation of β-Amyloid Peptide into Oligomeric Complexes.Dangers of the amyloid-β vaccination
P2860
Q33976829-E32014BA-BAA3-4063-90A2-7625030BAC45Q34009618-3145B1DF-EB80-463F-9003-BC141B453E7EQ34221510-A80E4A3D-6193-4B7E-B6C6-E514CB690F12Q34342742-7B51C33E-823A-4F73-B052-6F75F34BEB73Q34457296-D7B01B99-B908-485A-9F44-E642D8751C3FQ34669518-80E662FF-6E56-4C9B-9829-F91C396AF0BAQ34974866-FD01FE74-4C0C-42F0-9908-9059219EADEEQ34976296-CA2B279D-3EE8-482F-8F78-262C0D28D95BQ35207554-6622D024-B0AA-406A-881D-F1A75F46A9D5Q35898532-4AC2028C-A9D7-4D56-BC60-A3EA9ECC2BD6Q36016766-86238C62-64C7-458D-9933-823A5E0706A3Q36044202-46D35AE3-134F-48D4-A62C-AC1D88201379Q36135513-E914639E-015B-45A6-94BF-4233C8DBF549Q36600440-0A445F45-E816-4C6C-81E2-B7EA5FB8EF31Q36799584-B0D1872E-C932-4747-9517-B7D931102C94Q36800729-F31E323E-22A7-4F56-A7A3-CE023423F87CQ36802182-69219A84-8F00-4C07-AB2E-2FC5E09E1B16Q36817040-12964A21-3B28-4AA3-B9C7-B1260B27AE69Q37174350-80D8EED6-EC59-40EC-A720-0B7CF7010F7AQ37773826-D10AC0DA-2A0A-420F-AEDB-22909F88113BQ37996961-11A86100-BCE9-4842-9C91-4B67FA1E1129Q38094984-9219B1BC-83A1-4C00-873A-017A5FF05E2EQ38184783-16644B47-0529-4D7A-B53B-45E5C5EA38CDQ38352298-E7545C2E-B266-46A2-AA47-3106089FE186Q38365416-728E661E-82A5-4AF6-8ED8-B25E72352B29Q40510522-461B617B-17B7-4A6B-AABA-5CDF563403A1Q44461865-9062AAE6-A17C-45D3-B054-2346F7548138Q46644671-5C90FF0A-373B-4198-8698-B5118787B33FQ47431150-ABBEA061-8624-45E9-893E-EC64E30B7125Q48427440-20685A4D-8A8B-4207-B26B-B6295A85C41DQ48543646-4612741D-0182-4316-A6ED-4A50E05A07FDQ50559935-16E327E1-07D1-4B18-ABA7-2B36D53D74CFQ53073171-60CF877E-E842-4BB9-B54C-DC506B130989Q57342006-2881786D-E3FB-40D9-9189-59B6C28900AE
P2860
Copernicus revisited: amyloid beta in Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Copernicus revisited: amyloid beta in Alzheimer's disease.
@ast
Copernicus revisited: amyloid beta in Alzheimer's disease.
@en
type
label
Copernicus revisited: amyloid beta in Alzheimer's disease.
@ast
Copernicus revisited: amyloid beta in Alzheimer's disease.
@en
prefLabel
Copernicus revisited: amyloid beta in Alzheimer's disease.
@ast
Copernicus revisited: amyloid beta in Alzheimer's disease.
@en
P2093
P1476
Copernicus revisited: amyloid beta in Alzheimer's disease.
@en
P2093
Denisova NA
Shukitt-Hale B
P304
P356
10.1016/S0197-4580(00)00211-6
P50
P577
2001-01-01T00:00:00Z